Convergence Partners was formed in 2018 by experienced venture capital - and operational experts with a vision to establish a venture capital firm that actively supports the internationalisation and market access of European technology innovators to the 4 largest healthcare markets: US, China, India and Germany. Whereas our current investment focus is on EU HealthTech startups, Convergence is able to open its cross-border acceleration platform to any DeepTech company that is keen to accelerate growth through rapid internationalisation.
Please get in touch with us to discuss your growth and investment plans.
The Convergence Team is represented in Switzerland, Germany and Spain and has additional partner hubs in Asia and the US to effectively support the internationalization of our portfolio companies. The investment team is supported by experienced venture-and operating partners, a top-class advisory board and experienced local landing & scale-up partners.